Johnson & Johnson Submits Supplemental New Drug Application to Expand Indication of Prezcobix for HIV-1 in Children at Least 6 Years Old

Posted on by admin
1 min read

A similar application was also submitted to the EMA for the expanded use of Prezcobix to treat children aged 6 years and older with HIV.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours